Mucoadhesive intestinal devices for oral delivery of salmon calcitonin

Journal of Controlled Release

Volumn 172, Issue 3, 2013, Pages 753-762

  Gupta, Vivek ^a,b   Hwang, Byeong Hee ^a   Lee, Joohee ^a   Anselmo, Aaron C ^a   Doshi, Nishit ^a   Mitragotri, Samir ^a  

^a University of California   (United States)

^b KECK GRADUATE INSTITUTE   (United States)

Author keywords

Enteric coated capsule; Intestinal; Macromolecule; Oral; Patch; Peroral

Indexed keywords

ENTERIC-COATED CAPSULES; INTESTINAL; ORAL; PATCH; PERORAL;

DRUG PRODUCTS; MACROMOLECULES; MONOLAYERS; RATS;

BIOCHEMISTRY;

CARBOMER; CARBOXYMETHYLCELLULOSE; ETHYL CELLULOSE; PECTIN; SALCATONIN;

AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY DEVICE; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MUCOADHESION; MUCOADHESIVE INTESTINAL DEVICE; POLYMERIZATION; PRIORITY JOURNAL; TRANSDERMAL PATCH;

ENTERIC COATED CAPSULE; INTESTINAL; MACROMOLECULE; ORAL; PATCH; PERORAL;

ACRYLIC RESINS; ADHESIVENESS; ADMINISTRATION, ORAL; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CACO-2 CELLS; CALCITONIN; CARBOXYMETHYLCELLULOSE SODIUM; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; PECTINS; RATS; RATS, SPRAGUE-DAWLEY; SWINE;

EID: 84887134290     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.09.004     Document Type: Article

References (75)

1. P. Vlieghe, V. Lisowski, J. Martinez, and M. Khrestchatisky Synthetic therapeutic peptides: science and market Drug Discov. Today 15 2010 40 56
2. A. Fasano Novel approaches for oral delivery of macromolecules J. Pharm. Sci. 87 1998 1351 1356 (Pubitemid 28514140)
3. M. Morishita, and N.A. Peppas Is the oral route possible for peptide and protein drug delivery? Drug Discov. Today 11 2006 905 910 (Pubitemid 44403178)
4. M.A. Karsdal, K. Henriksen, M. Arnold, and C. Christiansen Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality BioDrugs 22 2008 137 144 (Pubitemid 351692844)
5. Y.H. Lee, and P.J. Sinko Oral delivery of salmon calcitonin Adv. Drug Deliv. Rev. 42 2000 225 238 (Pubitemid 30645779)
6. C.H. Chesnut III, M. Azria, S. Silverman, M. Engelhardt, M. Olson, and L. Mindeholm Salmon calcitonin: a review of current and future therapeutic indications Osteoporos. Int. 19 2008 479 491
7. F.J. de Paula, and C.J. Rosen Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling Horm. Metab. Res. 42 2010 299 306
8. M. Torres-Lugo, and N.A. Peppas Transmucosal delivery systems for calcitonin: a review Biomaterials 21 2000 1191 1196 (Pubitemid 30195716)
9. C.H. Chesnut III, S. Silverman, K. Andriano, H. Genant, A. Gimona, S. Harris, D. Kiel, M. LeBoff, M. Maricic, P. Miller, C. Moniz, M. Peacock, P. Richardson, N. Watts, and D. Baylink A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group Am. J. Med. 109 2000 267 276
10. P. Conte, and V. Guarneri Safety of intravenous and oral bisphosphonates and compliance with dosing regimens Oncologist 9 Suppl. 4 2004 28 37 (Pubitemid 39363166)
11. U.S. F.D.A. Oral osteoporosis drugs (bisphosphonates): drug safety communication - potential increased risk of esophageal cancer http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm264087.htm 2011 (FDA Safety Alert)
12. D.H. Manicourt, M. Azria, L. Mindeholm, E.J. Thonar, and J.P. Devogelaer Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis Arthritis Rheum. 54 2006 3205 3211 (Pubitemid 44622091)
13. R.H. Nielsen, A.C. Bay-Jensen, I. Byrjalsen, and M.A. Karsdal Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover Osteoarthritis Cartilage 19 2011 466 473
14. M. Feigh, K.V. Andreassen, S.T. Hjuler, R.H. Nielsen, C. Christiansen, K. Henriksen, and M.A. Karsdal Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats Menopause 20 2013 785 794
15. M. Feigh, K.V. Andreassen, A.V. Neutzsky-Wulff, S.T. Petersen, C. Hansen, A.C. Bay-Jensen, J.E. Henriksen, H. Beck-Nielsen, C. Christiansen, K. Henriksen, and M.A. Karsdal Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats Br. J. Pharmacol. 167 2012 151 163
16. M. Feigh, K. Henriksen, K.V. Andreassen, C. Hansen, J.E. Henriksen, H. Beck-Nielsen, C. Christiansen, and M.A. Karsdal A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats Diabetes Obes. Metab. 13 2011 911 920
17. M. Feigh, R.H. Nielsen, C. Hansen, K. Henriksen, C. Christiansen, and M.A. Karsdal Oral salmon calcitonin improves fasting and postprandial glycemic control in lean healthy rats Horm. Metab. Res. 44 2012 130 134
18. M.A. Karsdal, K. Henriksen, A.C. Bay-Jensen, B. Molloy, M. Arnold, M.R. John, I. Byrjalsen, M. Azria, B.J. Riis, P. Qvist, and C. Christiansen Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials J. Clin. Pharmacol. 51 2011 460 471
19. P.J. Sinko, Y.H. Lee, V. Makhey, G.D. Leesman, J.P. Sutyak, H. Yu, B. Perry, C.L. Smith, P. Hu, E.J. Wagner, L.M. Falzone, L.T. McWhorter, J.P. Gilligan, and W. Stern Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT) Pharm. Res. 16 1999 527 533 (Pubitemid 29191297)
20. D.H. Oh, K.H. Chun, S.O. Jeon, J.W. Kang, and S. Lee Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation Eur. J. Pharm. Biopharm. 79 2011 357 363
21. S.B. Petersen, L.G. Nielsen, U.L. Rahbek, M. Guldbrandt, and D.J. Brayden Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer Eur. J. Pharm. Sci. 48 2013 726 734
22. C. Chen, T. Fan, Y. Jin, Z. Zhou, Y. Yang, X. Zhu, Z.R. Zhang, Q. Zhang, and Y. Huang Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids Nanomedicine 8 2013 1085 1100
23. W.P. Cheng, C. Thompson, S.M. Ryan, T. Aguirre, L. Tetley, and D.J. Brayden In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes J. Control. Release 147 2010 289 297
24. A. Makhlof, M. Werle, Y. Tozuka, and H. Takeuchi A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa J. Control. Release 149 2011 81 88
25. D.A. Carr, M. Gomez-Burgaz, M.C. Boudes, and N.A. Peppas Complexation hydrogels for the oral delivery of growth hormone and salmon calcitonin Ind. Eng. Chem. Res. 49 2010 11991 11995
26. N.A. Peppas, K.M. Wood, and J.O. Blanchette Hydrogels for oral delivery of therapeutic proteins Expert Opin. Biol. Ther. 4 2004 881 887 (Pubitemid 38843225)
27. H. Hoyer, G. Perera, and A. Bernkop-Schnurch Noninvasive delivery systems for peptides and proteins in osteoporosis therapy: a retroperspective Drug Dev. Ind. Pharm. 36 2010 31 44
28. R.B. Shah, and M.A. Khan Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery J. Pharm. Sci. 93 2004 392 406 (Pubitemid 38174260)
29. D. Guggi, C.E. Kast, and A. Bernkop-Schnurch In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix Pharm. Res. 20 2003 1989 1994 (Pubitemid 38005530)
30. W. Cheng, S. Satyanarayanajois, and L.Y. Lim Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activity Pharm. Res. 24 2007 99 110 (Pubitemid 44902575)
31. S. Mansoor, Y.S. Youn, and K.C. Lee Oral delivery of mono-PEGylated sCT (Lys18) in rats: regional difference in stability and hypocalcemic effect Pharm. Dev. Technol. 10 2005 389 396 (Pubitemid 41291476)
32. J. Wang, D. Chow, H. Heiati, and W.C. Shen Reversible lipidization for the oral delivery of salmon calcitonin J. Control. Release 88 2003 369 380 (Pubitemid 36331879)
33. P. Shakya, N.V. Madhav, A.K. Shakya, and K. Singh Palatal mucosa as a route for systemic drug delivery: a review J. Control. Release 151 2011 2 9
34. K. Whitehead, Z. Shen, and S. Mitragotri Oral delivery of macromolecules using intestinal patches: applications for insulin delivery J. Control. Release 98 2004 37 45 (Pubitemid 38881605)
35. A. Bernkop-Schnurch, and G. Walker Multifunctional matrices for oral peptide delivery Crit. Rev. Ther. Drug Carrier Syst. 18 2001 459 501 (Pubitemid 33117496)
36. S. Eiamtrakarn, Y. Itoh, J. Kishimoto, Y. Yoshikawa, N. Shibata, M. Murakami, and K. Takada Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein Biomaterials 23 2002 145 152 (Pubitemid 33041348)
37. S.L. Tao, M.W. Lubeley, and T.A. Desai Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery J. Control. Release 88 2003 215 228 (Pubitemid 36287339)
38. S. Dash, P.N. Murthy, L. Nath, and P. Chowdhury Kinetic modeling on drug release from controlled drug delivery systems Acta Pol. Pharm. 67 2010 217 223
39. R.W. Korsmeyer, S.R. Lustig, and N.A. Peppas Solute and penetrant diffusion in swellable polymers. I. Mathematical modeling J. Polym. Sci., Part B: Polym. Phys. 24 1986 395 408
40. V. Gupta, N. Doshi, and S. Mitragotri Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system PLoS One 8 2013 e57136
41. I. Hubatsch, E.G. Ragnarsson, and P. Artursson Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers Nat. Protoc. 2 2007 2111 2119 (Pubitemid 351565848)
42. M. Thanou, J.C. Verhoef, J.H. Verheijden, and H.E. Junginger Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs Pharm. Res. 18 2001 823 828 (Pubitemid 32783519)
43. K. Albrecht, M. Greindl, C. Kremser, C. Wolf, P. Debbage, and A. Bernkop-Schnurch Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection J. Control. Release 115 2006 78 84 (Pubitemid 44415072)
44. R.B. Shah, M. Nutan, and M.A. Khan An enteric dualâ€controlled gastrointestinal therapeutic system of salmon calcitonin - I: preparation, characterization, and preclinical bioavailability in rats Clin. Res. Regul. Aff. 21 2004 81 96 (Pubitemid 38943426)
45. A.N. Uddin, N.K. Bejugam, S.G. Gayakwad, P. Akther, and M.J. D'Souza Oral delivery of gastro-resistant microencapsulated typhoid vaccine J. Drug Target. 17 2009 553 560
46. J. Usansky, A. Desai, and D. Tang-Liu PK functions for Microsoft Excel http://www.boomer.org/pkin/soft.html 2003
47. V. Grabovac, D. Guggi, and A. Bernkop-Schnurch Comparison of the mucoadhesive properties of various polymers Adv. Drug Deliv. Rev. 57 2005 1713 1723 (Pubitemid 41443475)
48. B.W. Purdue, N. Tilakaratne, and P.M. Sexton Molecular pharmacology of the calcitonin receptor Receptors Channels 8 2002 243 255
49. D. Malkov, R. Angelo, H.Z. Wang, E. Flanders, H. Tang, and I. Gomez-Orellana Oral delivery of insulin with the eligen technology: mechanistic studies Curr. Drug Deliv. 2 2005 191 197 (Pubitemid 40488628)
50. R.E. Steinert, B. Poller, M.C. Castelli, K. Friedman, A.R. Huber, J. Drewe, and C. Beglinger Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects Clin. Pharmacol. Ther. 86 2009 644 650
51. R. Abu-Huwaij, R.M. Obaidat, K. Sweidan, and Y. Al-Hiari Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine AAPS PharmSciTech 12 2011 21 27
52. R.M. Obaidat, A. Bader, W. Al-Rajab, G. Abu Sheikha, and A.A. Obaidat Preparation of mucoadhesive oral patches containing tetracycline hydrochloride and carvacrol for treatment of local mouth bacterial infections and candidiasis Sci. Pharm. 79 2011 197 212
53. L. Perioli, and C. Pagano Preformulation studies of mucoadhesive tablets for carbamazepine sublingual administration Colloids Surf. B Biointerfaces 102 2013 915 922
54. P.A. Ritger, and N.A. Peppas A simple equation for description of solute release II. Fickian and anomalous release from swellable devices J. Control. Release 5 1987 37 42 (Pubitemid 17106644)
55. J.D. Smart The basics and underlying mechanisms of mucoadhesion Adv. Drug Deliv. Rev. 57 2005 1556 1568 (Pubitemid 41443469)
56. A.J. Kinloch The science of adhesion: part 1 surface and interfacial aspects J. Mater. Sci. 15 1980 2141 2166 (Pubitemid 11435610)
57. N.A. Peppas, and P.A. Buri Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues J. Control. Release 2 1985 257 275 (Pubitemid 16195943)
58. K.K. Peh, and C.F. Wong Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties J. Pharm. Pharm. Sci. 2 1999 53 61
59. D. Tiwari, D. Goldman, R. Sause, and P.L. Madan Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations AAPS PharmSci 1 1999 E13
60. C.F. Wong, K.H. Yuen, and K.K. Peh An in-vitro method for buccal adhesion studies: importance of instrument variables Int. J. Pharm. 180 1999 47 57 (Pubitemid 29131442)
61. I.S. Ahmed, and J.W. Ayres Comparison of in vitro and in vivo performance of a colonic delivery system Int. J. Pharm. 409 2011 169 177
62. A. Szymanski-Exner, N.T. Stowe, K. Salem, R. Lazebnik, J.R. Haaga, D.L. Wilson, and J. Gao Noninvasive monitoring of local drug release using X-ray computed tomography: optimization and in vitro/in vivo validation J. Pharm. Sci. 92 2003 289 296 (Pubitemid 36169302)
63. I.A. Brewis, S. Howell, N.M. Hooper, A.J. Kenny, and A.J. Turner Membrane peptidase expression by confluent cultures of Caco-2 cells Biochem. Soc. Trans. 21 Pt 3 1993 252S (Pubitemid 23265665)
64. G. Camenisch, J. Alsenz, H. van de Waterbeemd, and G. Folkers Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight Eur. J. Pharm. Sci. 6 1998 317 324
65. B.J. Aungst Intestinal permeation enhancers J. Pharm. Sci. 89 2000 429 442
66. H.L. Luessen, B.J. de Leeuw, M.W. Langemeyer, A.B. de Boer, J.C. Verhoef, and H.E. Junginger Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo Pharm. Res. 13 1996 1668 1672 (Pubitemid 26426890)
67. H.L. Luessen, J.C. Verhoef, G. Borchard, C.M. Lehr, A.G. de Boer, and H.E. Junginger Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin Pharm. Res. 12 1995 1293 1298
68. L. Li, N.R. Mathias, C.L. Heran, P. Moench, D.A. Wall, and R.L. Smith Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers J. Pharm. Sci. 95 2006 326 335 (Pubitemid 43241975)
69. M. Licciardi, G. Pasut, G. Amato, C. Scialabba, A. Mero, M. Montopoli, G. Cavallaro, O. Schiavon, and G. Giammona PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery Eur. J. Pharm. Biopharm. 84 2013 21 28
70. Y. Fan, X. Li, Y. Zhou, C. Fan, X. Wang, Y. Huang, and Y. Liu Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions Int. J. Pharm. 416 2011 323 330
71. M. Cetin, M.S. Aktas, I. Vural, and M. Ozturk Salmon calcitonin-loaded Eudragit(R) and Eudragit(R)-PLGA nanoparticles: in vitro and in vivo evaluation J. Microencapsul. 29 2012 156 166
72. L. Wu, G. Zhang, Q. Lu, Q. Sun, M. Wang, N. Li, Z. Gao, Y. Sun, T. Li, D. Han, X. Yu, L. Wang, W. Sun, D. Zhao, Y. Wu, Y. Lu, and X. Chen Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats Drug Dev. Ind. Pharm. 36 2010 362 370
73. G. Perera, J. Barthelmes, A. Vetter, C. Krieg, C. Uhlschmied, G.K. Bonn, and A. Bernkop-Schnurch Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate Drug Deliv. 18 2011 415 423
74. K. Whitehead, N. Karr, and S. Mitragotri Safe and effective permeation enhancers for oral drug delivery Pharm. Res. 25 2008 1782 1788
75. K. Whitehead, N. Karr, and S. Mitragotri Discovery of synergistic permeation enhancers for oral drug delivery J. Control. Release 128 2008 128 133